Luis Torres Carretero

Luis Torres Carretero

Auto-generated profile, based on publicly available information

Luis Torres Carretero

Neurosurgery Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2020 in Brain Pathology
Verified
Journal Article
Open access
PDF file
MPMaría González‐Tablas Pimenta
María González‐Tablas Pimenta
AOAlvaro Otero-Rodríguez
Alvaro Otero-Rodríguez
DGDaniel Angel Arandia Guzman
Daniel Angel Arandia Guzman
DPDaniel Pascual‐Argente
Daniel Pascual‐Argente
LMLaura Ruíz Martín
Laura Ruíz Martín
MTMaría Dolores Tabernero
María Dolores Tabernero
The distribution and role of tumor‐infiltrating leucocytes in glioblastoma (GBM) remain largely unknown. Here, we investigated the cellular composition of 55 primary (adult) GBM samples by flow cytometry and correlated the tumor immune profile with patient features at diagnosis and outcome. GBM single‐cell suspensions were stained at diagnosis (n = 44) and recurrence following radiotherapy and chemotherapy (n = 11) with a panel of 8‐color monoclonal antibody combinations for the identification and enumeration of (GFAP+CD45−) tumor and normal astrocytic cells, infiltrating myeloid cells —i.e. microglial and blood‐derived tumor‐associated macrophages (TAM), M1‐like, and M2‐like TAM, neutrophils. and myeloid‐derived suppressor cells (MDSC)— and tumor‐infiltrating lymphocytes (TIL) —i.e. CD3+T‐cells and their TCD4+, TCD8+, TCD4−CD8−, and (CD25+CD127lo) regulatory (T‐regs) subsets, (CD19+CD20+) B‐cells, and (CD16+) NK‐cells—. Overall, GBM samples consisted of a major population (mean ± 1SD) of tumor and normal astrocytic cells (73% ± 16%) together with a significant but variable fraction of immune cells (24% ± 18%). Within myeloid cells, TAM predominated (13% ± 12%) including both microglial cells (10% ± 11%) and blood‐derived macrophages (3% ± 5%), in addition to a smaller proportion of neutrophils (5% ± 9%) and MDSC (4% ± 8%). Lymphocytes were less represented and mostly included TCD4+ (0.5% ± 0.7%) and TCD8+ cells (0.6% ± 0.7%), together with lower numbers of TCD4−CD8− T‐cells (0.2% ± 0.4%), T‐regs (0.1% ± 0.2%), B‐lymphocytes (0.1% ± 0.2%) and NK‐cells (0.05% ± 0.05%). Overall, three distinct immune profiles were identified: cases with a minor fraction of leucocytes, tumors with a predominance of TAM and neutrophils, and cases with mixed infiltration by TAM, neutrophils, and T‐lymphocytes. Untreated GBM patients with mixed myeloid and lymphoid immune infiltrates showed a significantly shorter patient overall survival versus the other two groups, in the absence of gains of the EGFR gene (p = 0.02). Here we show that immune cell infiltrates are systematically present in GBM, with highly variable levels and immune profiles. Patients with mixed myeloid and T‐lymphoid infiltrates showed a worse outcome.

22 July 2025 in Journal of Neuro-Oncology
Verified
Journal Article
Closed access
PDF file
PLPedro David Delgado López
Pedro David Delgado López
AMAntonio Montalvo-Afonso
Antonio Montalvo-Afonso
RGRoberto García-Leal
Roberto García-Leal
SMSergio Martín-García
Sergio Martín-García
Alfonso LagaresAlfonso Lagares
Alfonso Lagares
ECEva María Corrales-García
Eva María Corrales-García

24 July 2023 in Annual International Conference of the IEEE Engineering in Medicine and Biology Society
Verified
Conference Paper
Closed access
LTLuis Torres
Luis Torres
Jin-Ho LeeJin-Ho Lee
Jin-Ho Lee
THTaku Hachisu
Taku Hachisu
SPSandra Puentes
Sandra Puentes
Spasticity is a condition that profoundly impacts the ability to perform everyday tasks. However, its diagnosis requires trained physicians and subjective evaluations that may vary depending on the evaluator. Focal vibration of spastic muscles has been proposed as a non-invasive, pain-free alternative for spasticity modulation. We propose a system to estimate muscular tightness based on the propagation of elastic waves in the skin generated by focal vibration of the upper limb. The developed system generates focalized displacements on the biceps muscle at frequencies from 50 to 200 Hz, measures the vibration acceleration on the vibration source (input) and the distant location (output), and extracts features of ratios between input and output. The system was tested on 5 healthy volunteers while lifting 1.25 – 11.25 kg weights to increase muscle tone resembling spastic conditions, where the vibration frequency and weight were selected as explanatory variables. An increase in the ratio of the root mean squares proportional to the weight was found, validating the feasibility of the current approach to estimating muscle tightness.Clinical Relevance— This work presents the feasibility of a vibration-based system as an alternative method to objectively diagnose the degree of spasticity.

22 June 2023 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
AOAlvaro Otero-Rodríguez
Alvaro Otero-Rodríguez
DADaniel Angel Arandia-Guzman
Daniel Angel Arandia-Guzman
DPDaniel Pascual-Argente
Daniel Pascual-Argente
LRLaura Ruiz-Martin
Laura Ruiz-Martin
JOJuan-Carlos Roa-Montes de Oca
Juan-Carlos Roa-Montes de Oca
LCLaura Cid-Mendes
Laura Cid-Mendes

9 December 2021 in BMJ Open
Verified
Journal Article
Open access
PDF file
IPIgor Paredes
Igor Paredes
ALAna Maria Castaño Leon
Ana Maria Castaño Leon
Alfonso LagaresAlfonso Lagares
Alfonso Lagares
LJLuis Jimenez-Roldan
Luis Jimenez-Roldan
APAngel Perez-Nuñez
Angel Perez-Nuñez
GJGorka Zabalo San Juan
Gorka Zabalo San Juan
Objective: To assess the effect of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients in Spain. Settings: The initial flood of COVID-19 patients overwhelmed an unprepared healthcare system. Different measures were taken to deal with this overburden. The effect of these measures on neurosurgical patients, as well as the effect of COVID-19 itself, has not been thoroughly studied. Participants: This was a multicentre, nationwide, observational retrospective study of patients who underwent any neurosurgical operation from March to July 2020. Interventions: An exploratory factorial analysis was performed to select the most relevant variables of the sample. Primary and secondary outcome measures: Univariate and multivariate analyses were performed to identify independent predictors of mortality and postoperative SARS-CoV-2 infection. Results: Sixteen hospitals registered 1677 operated patients. The overall mortality was 6.4%, and 2.9% (44 patients) suffered a perioperative SARS-CoV-2 infection. Of those infections, 24 were diagnosed postoperatively. Age (OR 1.05), perioperative SARS-CoV-2 infection (OR 4.7), community COVID-19 incidence (cases/10 5 people/week) (OR 1.006), postoperative neurological worsening (OR 5.9), postoperative need for airway support (OR 5.38), ASA grade ≥3 (OR 2.5) and preoperative GCS 3–8 (OR 2.82) were independently associated with mortality. For SARS-CoV-2 postoperative infection, screening swab test <72 hours preoperatively (OR 0.76), community COVID-19 incidence (cases/10 5 people/week) (OR 1.011), preoperative cognitive impairment (OR 2.784), postoperative sepsis (OR 3.807) and an absence of postoperative complications (OR 0.188) were independently associated. Conclusions: Perioperative SARS-CoV-2 infection in neurosurgical patients was associated with an increase in mortality by almost fivefold. Community COVID-19 incidence (cases/10 5 people/week) was a statistically independent predictor of mortality. Trial registration number: CEIM 20/217.

27 February 2023 in Scientific Reports
Verified
Journal Article
Open access
JCJessica Comín
Jessica Comín
ACAlberto Cebollada
Alberto Cebollada
A(Aragonese Working Group on Molecular Epidemiology of Tuberculosis (EPIMOLA)
Aragonese Working Group on Molecular Epidemiology of Tuberculosis (EPIMOLA)
MIMaría José Iglesias
María José Iglesias
DIDaniel Ibarz
Daniel Ibarz
SSSofia Samper
Sofia Samper